14 Best Aggressive Growth Stocks to Buy According to Analysts

Page 12 of 13

2. Natera, Inc. (NASDAQ:NTRA)

Year-Over-Year Revenue Growth: 51.50%

Average Price Target Upside Potential According to Analysts: 42.73%

Number of Hedge Fund Holders: 67

Natera, Inc. (NASDAQ:NTRA) is one of the best aggressive growth stocks to buy according to analysts. On July 28, Evercore ISI initiated coverage on Natera, Inc. (NASDAQ:NTRA), giving an Outperform rating and setting the price target at $170.

The firm views Natera, Inc. (NASDAQ:NTRA) as a fast-growing diagnostics company. Evercore noted that the company has a “clear first-mover advantage” in Minimal Residual Disease (MRD) testing in oncology. The firm pointed out that Natera, Inc. (NASDAQ:NTRA) has the most clinically validated platform and holds about 80% of the market share.

Evercore also highlighted Natera, Inc.’s (NASDAQ:NTRA) top position in women’s health diagnostics. The company holds the leading market share position in areas like non-invasive prenatal testing (NIPT) and carrier screening services.

Natera, Inc. (NASDAQ:NTRA) is a clinical genetic testing company focused on oncology, women’s health, and organ health.

Page 12 of 13